In a breakthrough for AI-powered drug discovery, Insilico Medicine announced positive Phase IIa results for its novel drug ISM001-055, designed to treat Idiopathic Pulmonary Fibrosis (IPF). This small molecule, developed using Insilico’s proprietary generative...
Welcome, AI enthusiasts.Sam Altman just confirmed OpenAI's o1 models have reached level 2 of their 5-tier path to AGI, accelerating the leap towards level 3 (agents).With o1 improving daily, are we only a few...
Hanwha Solutions announced that it achieved its highest-ever sales and operating profit within the renewable energy sector last yr despite internal and external management uncertainties. It said that it has continued to speculate...